Allianz Asset Management Gmb H Arrowhead Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

$62.9 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $411,681 - $749,736	-14,814 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $1.08 Million - $1.91 Million	-27,278 Reduced 64.81%	14,814 $681,000
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $838,354 - $1.19 Million	14,432 Added 52.18%	42,092 $2.79 Million
Q3 2021 Nov 10, 2021	BUY	$58.38 - $84.96 $18,039 - $26,252	309 Added 1.13%	27,660 $1.73 Million
Q2 2021 Aug 16, 2021	SELL	$62.15 - $90.32 $400,991 - $582,744	-6,452 Reduced 19.09%	27,351 $2.27 Million

Q1 2021 May 13, 2021	SELL	$61.35 - $90.47 $2.2 Million - $3.25 Million	-35,932 Reduced 51.53%	33,803 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $2.53 Million - $4.93 Million	57,692 Added 479.05%	69,735 $5.35 Million
Q3 2020 Nov 13, 2020	BUY	$33.21 - $51.27 $24,176 - $37,324	728 Added 6.43%	12,043 $519,000
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $19,093 - $31,630	731 Added 6.91%	11,315 $489,000
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $1.28 Million - $3.92 Million	-62,075 Reduced 85.43%	10,584 $305,000
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $733,609 - $1.9 Million	26,070 Added 55.96%	72,659 $4.61 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $3.14 Million - $4.17 Million	-119,500 Reduced 71.95%	46,589 $1.31 Million
Q2 2019 Aug 08, 2019	SELL	$17.43 - $28.82 $760,924 - $1.26 Million	-43,656 Reduced 20.81%	166,089 $4.4 Million
Q1 2019 May 13, 2019	BUY	$12.05 - $20.18 $73,890 - $123,743	6,132 Added 3.01%	209,745 $3.85 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $2.19 Million - $4.01 Million	203,613 New	203,613 $2.53 Million
Q1 2018 May 14, 2018	SELL	$3.72 - $7.64 $1.72 Million - $3.53 Million	-462,105 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$3.14 - $4.5 $31,352 - $44,932	9,985 Added 2.21%	462,105 $1.7 Million
Q3 2017 Nov 13, 2017	BUY	$1.69 - $4.33 $361,724 - $926,784	214,038 Added 89.9%	452,120 $1.96 Million
Q3 2016 Apr 17, 2019	BUY	N/A	238,082	238,082 $1.75 Million

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.75B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account